Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New trends in cannabis potency in USA and Europe during the last decade (2008–2017)
Suman Chandra, Mohamed M. Radwan, Chandrani G. Majumdar, et al.
European Archives of Psychiatry and Clinical Neuroscience (2019) Vol. 269, Iss. 1, pp. 5-15
Closed Access | Times Cited: 405

Showing 1-25 of 405 citing articles:

Public health implications of legalising the production and sale of cannabis for medicinal and recreational use
Wayne Hall, Daniel Stjepanović, Jonathan P. Caulkins, et al.
The Lancet (2019) Vol. 394, Iss. 10208, pp. 1580-1590
Closed Access | Times Cited: 289
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis
Tom P. Freeman, Sam Craft, Jack Wilson, et al.
Addiction (2020) Vol. 116, Iss. 5, pp. 1000-1010
Open Access | Times Cited: 253
What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis
Janni Leung, Gary Chan, Leanne Hides, et al.
Addictive Behaviors (2020) Vol. 109, pp. 106479-106479
Closed Access | Times Cited: 211
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
Abigail M. Freeman, Kat Petrilli, Rachel Lees, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 696-712
Open Access | Times Cited: 181
‘Standard THC units’: a proposal to standardize dose across all cannabis products and methods of administration
Tom P. Freeman, Valentina Lorenzetti
Addiction (2019) Vol. 115, Iss. 7, pp. 1207-1216
Open Access | Times Cited: 172
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Tom P. Freeman, Chandni Hindocha, Gianluca Baio, et al.
The Lancet Psychiatry (2020) Vol. 7, Iss. 10, pp. 865-874
Open Access | Times Cited: 172
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals
Christopher A. Legare, Wesley M. Raup‐Konsavage, Kent E. Vrana
Pharmacology (2022) Vol. 107, Iss. 3-4, pp. 131-149
Open Access | Times Cited: 172
A Comprehensive Review of Cannabis Potency in the United States in the Last Decade
Mahmoud A. ElSohly, Suman Chandra, Mohamed M. Radwan, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2021) Vol. 6, Iss. 6, pp. 603-606
Closed Access | Times Cited: 171
Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets
Samantha Goodman, Elle Wadsworth, Cesar Leos‐Toro, et al.
International Journal of Drug Policy (2020) Vol. 76, pp. 102658-102658
Closed Access | Times Cited: 158
Cannabis and synaptic reprogramming of the developing brain
Anissa Bara, Jacqueline‐Marie N. Ferland, Gregory Rompala, et al.
Nature reviews. Neuroscience (2021) Vol. 22, Iss. 7, pp. 423-438
Open Access | Times Cited: 142
Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates
Jakob Manthey, Tom P. Freeman, Carolin Kilian, et al.
The Lancet Regional Health - Europe (2021) Vol. 10, pp. 100227-100227
Open Access | Times Cited: 126
Association of cannabis potency with mental ill health and addiction: a systematic review
Kat Petrilli, Shelan Ofori, Lindsey A. Hines, et al.
The Lancet Psychiatry (2022) Vol. 9, Iss. 9, pp. 736-750
Open Access | Times Cited: 126
Hemp seeds: Nutritional value, associated bioactivities and the potential food applications in the Colombian context
Lídia Montero, Diego Ballesteros-Vivas, Andrés Fernando González Barrios, et al.
Frontiers in Nutrition (2023) Vol. 9
Open Access | Times Cited: 43
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study
William Yang Wang, Nora D. Volkow, Nathan A. Berger, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 8, pp. 2587-2598
Open Access | Times Cited: 24
Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation
Syed Mahamad, Elle Wadsworth, Vicki Rynard, et al.
Drug and Alcohol Review (2020) Vol. 39, Iss. 4, pp. 337-346
Closed Access | Times Cited: 121
Mapping cannabis potency in medical and recreational programs in the United States
Mary Catherine Cash, Katharine Cunnane, Chuyin Fan, et al.
PLoS ONE (2020) Vol. 15, Iss. 3, pp. e0230167-e0230167
Open Access | Times Cited: 119
Adolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence
Valentina Lorenzetti, Eva Hoch, Wayne Hall
European Neuropsychopharmacology (2020) Vol. 36, pp. 169-180
Closed Access | Times Cited: 112
The Use of Alcohol, Tobacco, Illegal Drugs and Medicines
Josefine Atzendorf, Christian Rauschert, Nicki‐Nils Seitz, et al.
Deutsches Ärzteblatt international (2019)
Open Access | Times Cited: 105
Heavy cannabis use, dependence and the brain: a clinical perspective
Emese Kroon, Lauren Kuhns, Eva Hoch, et al.
Addiction (2019) Vol. 115, Iss. 3, pp. 559-572
Open Access | Times Cited: 102
Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults
Justin Matheson, Beth Sproule, Patricia Di Ciano, et al.
Psychopharmacology (2019) Vol. 237, Iss. 2, pp. 305-316
Closed Access | Times Cited: 90
Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review
Deborah S. Hasin, Claire Walsh
Journal of Clinical Medicine (2020) Vol. 10, Iss. 1, pp. 15-15
Open Access | Times Cited: 86
Communicating THC levels and ‘dose’ to consumers: Implications for product labelling and packaging of cannabis products in regulated markets
David Hammond
International Journal of Drug Policy (2019) Vol. 91, pp. 102509-102509
Closed Access | Times Cited: 82
Opportunities for cannabis in supportive care in cancer
Amber S. Kleckner, Ian R. Kleckner, Charles Kamen, et al.
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 82
Deconstructing the neurobiology of cannabis use disorder
Jacqueline‐Marie N. Ferland, Yasmin L. Hurd
Nature Neuroscience (2020) Vol. 23, Iss. 5, pp. 600-610
Open Access | Times Cited: 78
The short-term and long-term effects of cannabis on cognition: recent advances in the field
Emese Kroon, Lauren Kuhns, Janna Cousijn
Current Opinion in Psychology (2020) Vol. 38, pp. 49-55
Open Access | Times Cited: 73
Page 1 - Next Page

Scroll to top